Plasma-cell and tumor-associated membrane antigens of mouse plasmacytoma MOPC-315 and MOPC-460

Tumor-specific and tumor-associated membrane antigens of Rous sarcoma virus transformed hamster fibroblasts

Hamster fibroblasts transformed by an env- strain of Rous sarcoma virus (RSV) express at their surface tumor-associated antigens of unknown origin and a tumor-specific antigen (VCSA) which is not expressed by hamster fibroblasts transformed by unrelated DNA or RNA oncogenic viruses. This antigen was detectable by rabbit antibodies and a complement-dependent 51Cr-release cytotoxicity assay and is common to RSV-transformed cells of different animal species. By comparing the anti-VCSA serum which antisera directed against purified gp85, gs-proteins, reverse transcriptase or detergentlysed virus particles, it was shown that VCSA is not a known virion structural protein. Moreover, VCSA expression does not correlate with viral replication since it is not detectable in chick embryo fibroblasts productively infected with the transformation-defective virus RAV-1 which shares virus structural genes with RSV. Finally, in hamster cells transformed by an RSV mutant, temperature-sensitive for the ability to transform the host cell, VCSA expression at the cell surface correlates with the expression of the transforming gene.

Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes

Newborn mice have a lower spontaneous resistance to the growth of a syngeneic plasmacytoma (MOPC-460) as compared to adult mice. The transfer of different leucocyte populations from non-immunized adult donors to newborn mice influence in a dual way the resistance to MOPC-460 growth, depending on the number of cells transferred. The transfer of a low number of neutrophils, thymus or spleen cells enhances the MOPC-460 takes. Higher numbers of neutrophils, thymus or bone marrow cells induce an effective protenction. By contrast, macrophages over a dose of 1 X 10(4) constantly produce a reduction of tumour growth.